Design for immuno-oncology clinical trials enrolling both responders and nonresponders (Q6629846)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Design for immuno-oncology clinical trials enrolling both responders and nonresponders |
scientific article; zbMATH DE number 7936087
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design for immuno-oncology clinical trials enrolling both responders and nonresponders |
scientific article; zbMATH DE number 7936087 |
Statements
Design for immuno-oncology clinical trials enrolling both responders and nonresponders (English)
0 references
30 October 2024
0 references
cancer immunotherapy
0 references
clinical trial
0 references
dichotomized response
0 references
immuno-oncology trial
0 references
nonproportional hazards pattern
0 references
proportional hazards assumption
0 references
sample size and power calculation
0 references
